Consistently, clinical experiments have also demonstrated that FGF21 and growth differentiation factor 15 (GDF15) are potential markers of mitochondrial dysfunction, muscle dysplasia, and genetic disorders deficient in oxidative phosphorylation [43,44]. This evidence concerns the gene GDF15 and hereditary disease.